| Time |
Room |
|
Activity |
| 08:00-09:30 | Room 1 - Alfredo Halpern | SESSION: SOCIAL MEDIA AND OBESITY
20 | Social media and eating disorders in young people
20 | Social media and obesity: how to communicate correctly?
20 | People with obesity perspective: stigma in the digital world
30 | Discussion |
| 08:00-09:30 | Room 2 - John Waterlow | SESSION: OBESITY AND THE HEART
20 | Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets
20 | Mechanisms linking atherosclerosis to obesity
20 | Impact of bariatric surgery in hypertension and heart failure
30 | Discussion |
| 08:00-09:30 | Room 4 - Peter Kopelman | SYMPOSIUM: SBD-ABESO - OBESITY AND TYPE 2 DIABETES
15 | Obesity and weight management for prevention of T2DMSpeaker: João Eduardo Nunes Salles (SP)
15 | MASH in diabetes: should we be worried about liver or cardiovascular outcomes?
15 | Remission of diabetes with clinical weight loss: a viable approach?
15 | Metabolic surgery in T2D: unraveling the role of WL in T2D improvement and remission
30 | Discussion |
| 08:00-09:30 | Room 3 - Bernard Jeanrenaud | SESSION: OBESITY AND THE BRAIN
08 | Abstracts - 128974: HYPOTHALAMIC CXCR3+ IMMUNE CELL RECRUITMENT PROTECTS MICE FROM HIGH-FAT DIET-INDUCED METABOLIC DYSFUNCTION. - Presenter: Natalia Ferreira Mendes
20 | The set point vs the dual intervention point models and body weight regulation
20 | Melanocortins, obesity and the brain – unveiling myths and factsSpeaker: Marcelo Rubinstein (Argentina)
20 | Brain responses to nutrients in obesity and after weight loss
22 | Discussion |
| 08:00-09:30 | Room 5 - Phillip James | SESSION: COMMERCIAL DETERMINANTS OF HEALTH - FROM TOBACCO AND ALCOHOL TO SSB AND UPFS INDUSTRY
Duração: 15 min.
Duração: 15 min.
Duração: 15 min.
Duração: 15 min.
15 | Discussion |
| 09:30-10:30 | Room 1 - Alfredo Halpern | KEYNOTE LECTURE: HOW ADIPOSE TISSUE DYSFUNCTION CAN EXPLAIN METABOLIC HEALTH AND IR IN OBESITY AND T2D?
Duração: 45 min.
15 | Discussion |
| 09:30-10:00 | Room 2 - John Waterlow | BREAK |
| 09:30-10:00 | Room 3 - Bernard Jeanrenaud | BREAK |
| 09:30-10:30 | Room 5 - Phillip James | SESSION: ECONOMIC IMPACT OF OBESITY
Forecasting the costs and the economic impacts of public policies on overweight and obesity in Brazil
The Economic Burden of Obesity in Brazil
Health and economic costs of different Canadian policies to address obesity and NCDs |
| 09:30-10:30 | Room 6 - Rafael Gomez-Cuevas | SESSION: MAIN FINDINGS ON OBESITY AND METABOLIC DISEASES IN THE ELSA BRAZIL STUDY |
| 09:30-10:30 | Room 4 - Peter Kopelman | SYMPOSIUM: OTHER WAYS TO LOOK INTO OBESITY
20 | Weight trajectory and maximum weight in life as a key information in obesity treatment: a proposal by ABESO/SBEM
20 | Edmonton Obesity Staging System – what´s new?
20 | Discussion |
| 10:00-11:00 | Room 3 - Bernard Jeanrenaud | KEYNOTE LECTURE: THE FIRST DECADE OF GLOBAL FOOD POLICY – THE PAST AND THE PRESENT
Duração: 45 min.
15 | Questions |
| 10:00-11:00 | Room 2 - John Waterlow | MAIN CONFERENCE: HOW STIGMA IMPACTS HEALTH?
Duração: 45 min.
15 | Discussion |
| 10:30-11:00 | Room 5 - Phillip James | BREAK |
| 10:30-11:00 | Room 4 - Peter Kopelman | BREAK |
| 10:30-11:00 | Room 6 - Rafael Gomez-Cuevas | BREAK |
| 10:30-11:00 | Room 1 - Alfredo Halpern | BREAK |
| 11:00-12:30 | Room 1 - Alfredo Halpern | SYMPOSIUM: IFSO-WOF THE COMBINATION OF DRUGS AND SURGERYCoordinator: Ricardo Vitor Cohen (SP)
15 | Long term outcomes and safety of metabolic surgerySpeaker: Ricardo Vitor Cohen (SP)
15 | Will efficacious modern pharmacotherapy replace metabolic surgery?
15 | Improving the results of MS adding medical treatment
15 | What can internists expect after sustained weight loss with pharmacotherapy: lessons learned from bariatric surgerySpeaker: Carlos Schiavon (SP)
15 | Uptake of obesity treatments: what do patients thinkSpeaker: Ricardo Vitor Cohen (SP)
15 | Discussion |
| 11:00-12:30 | Room 2 - John Waterlow | SESSION: SITTING TIME AND SEDENTARISM
20 | Physiology of sedentarism
20 | Is sitting time a risk factor independent of overall physical activity?
20 | “Exercise snacks” as an approach to reduce sedentarism and improve outcomes
30 | Discussion |
| 11:00-12:30 | Room 3 - Bernard Jeanrenaud | SYMPOSIUM: CANCER AND OBESITY
20 | Obesity as a risk factor for cancer: putative mechanisms
20 | Sex differences on the impact of obesity and its treatment on cancer outcomes
20 | Lifestyle interventions to prevent cancer incidence and recurrence
08 | Abstract
22 | Discussion |
| 11:00-12:30 | Room 4 - Peter Kopelman | SESSION: SURMOUNT-OSA TRIAL RESULTS: TIRZEPATIDE FOR THE TREATMENT OF OBSTRUCTIVE SLEEP APNEA AND OBESITY
10 | Obesity and Obstructive Sleep Apnea – Setting the scene
15 | OSA: clinical characteristics and current therapeutic landscape
15 | Surmont-OSA: study design and results
30 | Panel Discussion: Putting Surmount-OSA results in context and its implications to clinical care |
| 11:00-12:30 | Room 6 - Rafael Gomez-Cuevas | SESSION: ABSTRACTS - CLINICAL 1
129700 - ASSESSMENT OF CARDIOMETABOLIC COMORBIDITIES IN ADULTS WITH OSTEOGENESIS IMPERFECTA
128850 - GLP-1 RECEPTOR AGONISTS AND THE RISK OF CHOLANGIOCARCINOMA IN INDIVIDUALS WITH TYPE 2 DIABETES WITH OVERWEIGHT/OBESITY: A LARGE POPULATION-BASED NATIONALWIDE MATCHED COHORT STUDY.
129778 - COMBINATION OF TOPIRAMATE AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN REAL-WORLD CLINICAL PRACTICE
129933 - PROBIOTIC SUPPLEMENTATION DID NOT ENHANCE THE EFFECTS OF CONTINUOUS CALORIE RESTRICTION ON BODY ADIPOSITY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
128926 - RELATIONSHIPS BETWEEN BLOOD DNA METHYLATION, DIET QUALITY AND METABOLIC HEALTH IN A SPANISH POPULATION
129783 - CORRELATION OF THE BUTYRATE-PRODUCING BACTERIUM FECALIBACTERIUM PRAUSNITZII WITH A BETTER METABOLIC PROFILE IN WOMEN
Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results from the STEP 9 randomised clinical trial |
| 11:00-12:30 | Room 5 - Phillip James | SESSION: ADDRESSING RIGHTS, INEQUALITY, GENDER, RACE AND SOCIAL DETERMINANTS OF HEALTH
5 | Abstracts - 129059: ASSOCIATION BETWEEN OBESITY AND THE INTERSECTION OF DEPRESSION, GENDER, AND RACE IN BRAZILIAN ADULTS - Presenter: Taciana Maia de Sousa
Duração: 20 min.
60 | Discussion PanelNzama Mbalati (South Africa) |
| 12:30-14:00 | Room 1 - Alfredo Halpern | BREAK |
| 12:30-13:30 | Room 2 - John Waterlow | SATELLITE SYMPOSIUM - BOEHRINGER-INGELHEIM: (RESTRICTED TO PRESCRIBERS)
The Weight of Health: Redefining Success in Obesity Management
(RESTRICTED TO PRESCRIBERS)
5 | Welcome
25 | More than Numbers: A Deeper Look at Obesity
15 | The Role of the Liver: Orchestrating Metabolism and Beyond
15 | Q&A |
| 12:30-13:30 | Room 3 - Bernard Jeanrenaud | SATELLITE SYMPOSIUM - ASTRAZENECA
Woman, 58 years old, BMI 29, complains of fatigue: Should I consider HFpEF?
Restricted to Prescribers |
| 12:30-13:30 | Room 5 - Phillip James | SATELLITE SYMPOSIUM - EMS
The Future of Obesity Treatment: Progress Driven by New Technologies and Solutions. Artificial Intelligence and Its Perspectives
Moderator: CHRISTINA ECCLISSATO
Speaker: WALMIR COUTINHO |
| 12:30-13:30 | Room 4 - Peter Kopelman | SATELLITE SYMPOSIUM - TAKEDA
Treatment of Eating Disorders in Patients with Obesity: What is the Best Approach for Different Patient Profiles?
Speaker: ADRIANO SEGAL
Speaker: PRISCILLA GIL |
| 12:30-14:00 | Room 6 - Rafael Gomez-Cuevas | BREAK |
| 14:00-16:00 | Room 1 - Alfredo Halpern | SESSION: LIPEDEMA: AN UNKNOWN DISEASE
*Partnership with Lipedema Foundation
20 | Lipedema: understanding the clinical diagnosis and the research landscape
15 | Physiopathology of lipedema
15 | Effect of weight loss in adipose tissue remodeling and metabolic function in women with Lipedema
10 | Diagnosis and clinical treatment options
8 | Surgical treatment
15 | Patient´s voice – living with lipedema
10 | Discussion |
| 14:00-15:30 | Room 2 - John Waterlow | ROUND TABLE: LIVING WITH OBESITY: HOW STIGMA SHAPED MY LIFE AND MY SEARCH FOR TREATMENTSDebater: Amber Huett-garcia (United States) |
| 14:00-15:30 | Room 3 - Bernard Jeanrenaud | SESSION: NEUROSCIENCE ON DIETS
08 | Abstracts - 128922: IPREVENT: INCREASING COLONIC PROPIONATE FOR THE PREVENTION OF WEIGHT GAIN IN YOUNGER ADULTS, A 12-MONTH RANDOMISED CONTROLLED TRIAL. - Presenter: Jennifer Pugh
20 | Ketones and the brain: myths, facts and presumptions
20 | Artificial sweeteners and brain response
20 | Saturated/Unsaturated fat and brain inflammation
22 | Discussion |
| 14:00-15:30 | Room 4 - Peter Kopelman | SESSION: EPIGENETICS OF OBESITY
20 | The intra-uterine environment and long term offspring risks
20 | Father obesity and lifestyle factors and offspring risks
20 | Breastfeeding and Its Impacts on Offspring and Mother: Long-Term Clinical-Epidemiological Evidence
30 | Discussion |
| 14:00-15:30 | Room 6 - Rafael Gomez-Cuevas | SESSION: ABSTRACTS - CLINICAL 2Judge: João Eduardo Nunes Salles (SP)
Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves metabolic risk factors in adults living with obesity: analysis of a placebo-controlled, randomised phase 2 trial
129848 - ASSESSMENT OF THE PERFORMANCE OF BODY ADIPOSITY INDEXES, RELATIVE FAT MASS AND BODY ROUNDNESS IN THE ASSESSMENT OF BODY ADIPOSITY AND INSULIN RESISTANCE IN ADULTS
128863 - ADOLESCENTS WITH HIGHER CALORIC INTAKE AT LATER HOURS ARE MORE LIKELY TO HAVE AN INCREASED RISK OF EXCESS WEIGHT: RESULTS FROM A POPULATION-BASED STUDY
129851 - GRAZING AFTER BARIATRIC SURGERY: PSYCHIATRIC COMORBIDITY AND WEIGHT OUTCOMES
128961 - OPTIMIZATION OF PATIENT ENGAGEMENT IN THE PHASE 3 CLINICAL TRIAL PROGRAM FOR SURVODUTIDE IN OBESITY THROUGH SIMULATION
128571 - METABOLIC PROFILE AND ITS RISKS IN A NON-DIABETIC POPULATION UNDERGOING KIDNEY TRANSPLANT
128581 - THE ANTIVIRAL IMMUNE DEFENSE MAY BE ADVERSELY INFLUENCED BY WEIGHT LOSS THROUGH A CALORIE RESTRICTION PROGRAM IN OBESE WOMEN |
| 14:00-15:00 | Room 5 - Phillip James | SESSION: FISCAL MEASURES FOR TACKLING MALNUTRITION IN ALL ITS FORMS
Brazilian Tax Reform- Civil Society advocating for health and sustainable diets
The new basic basket and fiscal policies in Brazil |
| 15:00-15:30 | Room 5 - Phillip James | SESSION: ABSTRACTS
5 | Abstract - 128988: INCIDENT CASES AND DEATHS ATTRIBUTABLE TO OVERWEIGHT AND OBESITY IN BRAZIL UNTIL 2044
5 | Abstract - 128689: ASSOCIATION OF THE COST WITH THE ENVIRONMENTAL IMPACT OF THE CURRENT AS WELL AS HEALTHY AND SUSTAINABLE DIETS IN BRAZIL
5 | Abstract - 129731: THE GLOBAL DIET QUALITY SCORE, COMPARED TO OTHER HEALTHY DIET METRICS, AND TYPE 2 DIABETES RISK - ELSA-BRASIL COHORT STUDY
5 | Abstract - 129050: NUTRITIONAL STATUS, FOOD CONSUMPTION, AND ENVIRONMENTS OF CHILDREN IN CITIES ENGAGED IN OBESITY PREVENTION IN SÃO PAULO, BRAZIL |
| 15:30-16:30 | Poster Area - Per Bjorntorp | REFRESHMENT BREAK AND POSTER SESSION
E-poster 1
E-poster 2
E-poster 3
E-poster 4
access abstracts |
| 15:30-16:30 | Room 3 - Bernard Jeanrenaud | REFRESHMENT BREAK AND POSTER SESSION |
| 15:30-16:30 | Room 4 - Peter Kopelman | REFRESHMENT BREAK AND POSTER SESSION |
| 15:30-16:30 | Room 6 - Rafael Gomez-Cuevas | REFRESHMENT BREAK AND POSTER SESSION |
| 15:30-16:30 | Room 5 - Phillip James | REFRESHMENT BREAK AND POSTER SESSION |
| 16:00-16:30 | Room 1 - Alfredo Halpern | REFRESHMENT BREAK AND POSTER SESSION |
| 16:30-18:00 | Room 1 - Alfredo Halpern | SESSION: THE CHALLENGE OF WEIGHT MAINTENANCE
08 | Abstracts - 129826: EFFECTS OF MIRABEGRON AND QUINOLONE ON THE ACTIVATION OF BROWN ADIPOSE TISSUE IN HUMANS (MIRAQL-BAT STUDY) - Presenter: Marcelo Miranda de Oliveira de Lima
20 | Physiology of the weight loss plateau in response to lifestyle intervention, novel pharmacological therapy and bariatric surgery
20 | How to reduce barriers for the long term pharmacological treatment of obesity?
20 | What do we know about successful weight maintainers?
22 | Discussion |
| 16:30-18:00 | Room 2 - John Waterlow | SESSION: OBESITY IN THE ELDERLY: IMPACT ON MUCLES AND BONES
08 | Abstracts - 128677: HIGH-INTENSITY INTERVAL TRAINING IMPROVES CARDIOMYOCYTE CONTRACTILE FUNCTION AND INTRACELLULAR CALCIUM HANDLING IN OBESE RATS - Presenter: André Soares Leopoldo
20 | Sarcopenic obesity: emerging mechanisms and diagnosis Speaker: João Eduardo Nunes Salles (SP)
20 | Obesity and skeletal fragility
20 | Skeletal muscle and metabolic health: how do we increase muscle mass and function in people with obesity and type 2 Diabetes?
22 | Discussion |
| 16:30-17:30 | Room 3 - Bernard Jeanrenaud | MEET THE EXPERT: BINGE EATING DISORDER – FROM DIAGNOSIS TO LONG TERM MANAGEMENT
Duração: 60 min.Speaker: Jose Carlos Appolinario (RJ) |
| 16:30-17:30 | Room 6 - Rafael Gomez-Cuevas | MEET THE EXPERT: SCREENING, DIAGNOSIS, TREATMENT AND FOLLOW UP OF PATIENTS WITH MASLD/MASH |
| 16:30-18:00 | Room 4 - Peter Kopelman | IDF/WOF JOINT SYMPOSIUM: INTERNATIONAL DIABETES FEDERATION POSITION STATEMENT FOR THE DIAGNOSIS OF INTERMEDIATE HYPERGLYCEMIA AND TYPE 2 DIABETESCoordinator: Hermelinda Pedrosa (DF)
35 | Introduction remarks - WOF and IDF Chairs
25 | The IDF new Position Statement: novel criteria for the diagnosis of DiabetesSpeaker: Akthar Hussain (Norway)
25 | Rationale for the IDF Task Force recommendations for the diagnosis of IH and Type 2 diabetesSpeaker: Maria Ines Schmidt (RS)
20 | Implications of the recommendation for the prevention and management of obesity/diabetes and its complications
15 | Discussion |
| 16:30-18:30 | Room 5 - Phillip James | SESSION: ABSTRACTS - PUBLIC HEALTH 1
129072 - PICKING THE RIGHT NUTRIENT PROFILING MODEL FOR FRONT-OF-PACK NUTRITIONAL LABELING: A RANDOMIZED EXPERIMENT IN AN ONLINE STORE SETTING WITH BRAZILIAN CONSUMERS
128331 - ASSESSING FOOD AVAILABILITY AND HEALTHIER OPTIONS IN AN URBAN CHINESE UNIVERSITY: A CASE STUDY USING THE CHINESE NUTRITION ENVIRONMENT MEASUREMENT SURVEY FOR STORES (C-NEMS-S)
128506 - A TRIAL OF ADULT OBESITY PREVENTION PROCEDURE IN PRIMARY MEDICAL INSTITUTES
128569 - PERCEPTIONS, ATTITUDES, BEHAVIORS, AND BARRIERS TO EFFECTIVE OBESITY CARE: AN EXPLORATORY SURVEY-BASED STUDY AMONG PEOPLE WITH OBESITY AND HEALTHCARE PROFESSIONALS IN INDONESIA
129008 - EMOTIONAL APPEALS IN SODA ADS: IMPACT ON CHILDREN’S CHOICES AND POLICY IMPLICATIONS
129060 - CHILDHOOD OVERWEIGHT AND ITS ASSOCIATION WITH SOCIOECONOMIC AND ENVIRONMENTAL DETERMINANTS IN BRAZILIAN MUNICIPALITIES |
| 17:30-18:30 | Room 6 - Rafael Gomez-Cuevas | MEET THE EXPERT: SLEEP APNEA – FROM DIAGNOSIS, TO THE CLINICAL IMPACT OF CPAP AND WEIGHT LOSSSpeaker: Geraldo Lorenzi Filho (SP) |
| 17:30-18:30 | Room 3 - Bernard Jeanrenaud | MEET THE EXPERT: MEASURING BODY COMPOSITION ON CLINICAL PRACTICE: HOW TO USE BIA, DXA AND OTHERS |
